A team at the University of Glasgow reported in Science Thursday that they have made a series of 3-D printable reaction vessels, or “reactionware,” that can be used to turn simple compounds into medicines.
Why use 3-D printing? “This approach will allow the on-demand production of chemicals and drugs that are in short supply, hard to make at big facilities, and allow customization to tailor them to the application,” says Leroy Cronin, one of the paper's authors.
The benefit: Printable tools could encourage drug makers to create medicines for rare diseases that would be too costly to manufacture using conventional methods.
The risk: The reactionware might also be used for ill deeds, like synthesizing illegal drugs. But as with 3-D printed guns, it's likely still more trouble than it's worth.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.